For primary care, dermatology, OBGYN, and urology practices

A new revenue line. Clinical visibility kept.

Your patients are already paying $300+ a month for GLP-1s, hair loss, peptides, and TRT at telehealth companies you've never heard of. You see none of that revenue and none of what they're taking. Build.MD lets you prescribe those programs yourself — in the office or virtually — and keep your patients.

01 — THE OPPORTUNITY

The demand is already in your panel.

Patients are buying these programs somewhere. Bringing them in-house adds cash-pay revenue without adding staff.

$300+/mo
What patients already pay elsewhere for GLP-1s, TRT, and hair loss
14 days
Go-live in as fast as 14 days from first call
$105,000
Estimated yearly revenue from a 150-patient panel (illustrative)
Every Rx
Stays visible to you — no blind spots in what patients take
02 — BUILT FOR PRACTICES

Built for how a practice actually runs.

The five things practices ask about first — and how to join the first cohort.

01 — IN-OFFICE PRESCRIBING
Prescribe during the visit

Start a patient on a program while they're in the room, or virtually afterwards. No second appointment, no new staff.

02 — PRACTICE QR JOIN
Patients join from the waiting room

Your practice gets its own QR code. Patients scan it, complete intake on their phone, and join your panel.

03 — YOUR PATIENTS
You keep your patients

Patients you bring onto the platform stay your patients. We'll walk you through exactly how the agreement says it.

04 — COPY FOR EMR
Notes that reach your chart

A bridge, not an integration: copy finalized, signed notes — provenance-stamped — into your EMR.

05 — NEW REVENUE
A cash-pay line without new staff

Add revenue from programs your patients already want. Size it with the calculator below, then we'll walk through the specifics for your practice.

06 — EARLY ACCESS
Join the first cohort

We're onboarding our first cohort of practices now: early access and a direct line to the team.

03 — REVENUE MATH

Your panel, your math.

Drag to size your cash-pay patient panel and see an estimate of what it adds.

REVENUE CALCULATOR

Your panel, your math.

Drag to size your cash-pay patient panel.

Active patients150

Illustrative estimate. Your numbers depend on your panel and the programs you offer — we'll walk through the specifics on a call.

ESTIMATED MONTHLY REVENUE
$8,750
to your practice
ESTIMATED YEARLY REVENUE
$105,000
from cash-pay programs
04 — WHAT WE HANDLE

What you do. What we do.

You stay close to your patients and your brand. We run the clinical and operational backbone underneath.

YOU
What stays yours
See your patients — in the office or virtually
Choose which programs to offer
Keep your patients and your brand
Stay the clinical decision-maker
BUILD.MD
What we run
Clinical protocols and provider coverage where you want it
E-prescribing and closed pharmacy routing
Patient intake, CRM, and retention
Billing, compliance, and reporting
Vetted 503A and 503B pharmacy partners
Optional operational support — patient messaging and coordination
Go-live in as fast as 14 days
05 — PROGRAMS

Programs you can offer.

Seven prescription programs, each fully built. Start with one and add more as you grow.

Weight loss

Compounded semaglutide and tirzepatide. Brand GLP-1 available.

Men's health

Sildenafil, tadalafil, libido and performance protocols.

Hair loss

Finasteride, minoxidil. FDA-approved protocols.

Derm

Acne, anti-aging, custom topical prescriptions.

Peptide therapy

Tesamorelin and sermorelin, physician-supervised.

Longevity

Physician-supervised longevity protocols, off-label.

Brand GLP-1

Wegovy and Zepbound with insurance concierge.

06 — WORKED EXAMPLES

Three ways it could work.

Illustrative examples with modeled numbers — not customer results. We're onboarding our first cohort now.

EXPAND · EXAMPLE
A dermatology group adds weight loss and hair loss.

SituationPatients keep asking for GLP-1s and hair-loss treatment. The group has no cash-pay setup.

SetupPhysicians prescribe in the office. Build.MD runs intake, pharmacy routing, and refills under the group's name.

150 active patients × $700 a year ≈ $105,000 a year
No new staff or software to buy
RETAIN · EXAMPLE
A primary care practice keeps its GLP-1 patients.

SituationPatients are getting semaglutide from companies the physician has never heard of.

SetupThe practice offers a cash-pay weight loss program alongside primary care, and every Rx stays visible.

75 active patients × $58.33 a month ≈ $4,375 a month
Patients stay on one record
ADD · EXAMPLE
A urology practice adds men's health.

SituationSteady demand for ED and performance Rx, and no virtual workflow to handle it.

SetupFDA-approved generics on a virtual intake, with a live visit where state law requires one.

50 active patients × $700 a year ≈ $35,000 a year
Go-live in as fast as 14 days
07 — COMMON QUESTIONS

Questions, answered.

Yes. Patients you bring onto the platform stay your patients, and we'll walk you through the agreement language on a call.

EARLY ACCESS

Add cash-pay programs to your practice.

We're onboarding our first cohort of practices now. Tell us about your practice — we'll confirm fit before either of us spends more time.

Apply for early access →
06 — APPLY FOR EARLY ACCESS

We're onboarding a small cohort first.

Build.MD is in early access. We're working with a focused group of operators across providers, medspas, fitness, brands, and enterprise before opening broadly. Tell us what you're building; we'll come back within the next business day if there's a fit.

1
1-minute applicationTell us your business, what you're solving, rough volume.
2
Fit review within 24 hoursWe respond either way. If it's not a fit, we'll tell you and suggest alternatives.
3
15-minute call if there's a fitWe walk through how Build.MD would work for your specific business.
4
Scoped proposal within 24 hoursIf we both want to move forward, you get a real proposal with timeline and investment.
EARLY ACCESS APPLICATION
Tell us about your business
We'll get back to you within the next business day. No spam, no follow-up cycle if it's not a fit.